Association Between Effectiveness of Mirikizumab and UC Patients with High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06626165
- Locations
- π―π΅
Showa Inan General Hospital, Komagane, Nagano, Japan
Association Between LRG and Histologic Remission in Ulcerative Colitis
Recruiting
- Conditions
- Ulcerative Colitis in Histologic Remission
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06372613
- Locations
- π―π΅
Showa Inan General Hospital, Komagane, Japan
Injured Submucosal Arteries After CSP for 10-19 mm Nonpedunculated Colorectal Polyps.
Not Applicable
Completed
- Conditions
- Colonic Polyp
- Interventions
- Procedure: Active Comparator HS-EMRProcedure: Experimental CSP
- First Posted Date
- 2023-07-05
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT05930041
- Locations
- π―π΅
Showa Inan General Hospital, Komagane, Nagano, Japan
Safety of Propofol Sedation ( > 200 mg) for Colonoscopy.
Completed
- Conditions
- Safety Issues
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05213208
- Locations
- π―π΅
Showa Inan General hospital, Komagane, Nagano, Japan
The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole
Not Applicable
Completed
- Conditions
- Gastroesophageal Reflux
- Interventions
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT04720781
- Locations
- π―π΅
Showa Inan General hospital, Komagane, Nagano, Japan
Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
Completed
- Conditions
- LRG Levels
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 125
- Registration Number
- NCT04535882
- Locations
- π―π΅
Showa Inan General Hospital, Komagane, Nagano, Japan
The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis
Not Applicable
Recruiting
- Conditions
- Pneumatosis Cystoides Intestinalis
- Interventions
- Drug: Japanese traditional medicine group
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04368663
- Locations
- π―π΅
Showa Inan General hospital, Komagane, Nagano, Japan
Linked-color Imaging for the Detection of Colorectal Flat Lesions
Not Applicable
Completed
- Conditions
- Colonic Polyp
- Interventions
- Procedure: Linked-color imaging
- First Posted Date
- 2017-09-06
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT03272945
- Locations
- π―π΅
Showa Inan General hospital, Komagane, Nagano, Japan
Comparison of Pureed Rice Using a Gelling Agent and Standard Pureed Rice
Not Applicable
Completed
- Conditions
- Swallowing Disorder
- Interventions
- Other: a gelling agent
- First Posted Date
- 2017-05-23
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03163355
- Locations
- π―π΅
Showa Inan General hospital, Komagane, Nagano, Japan
Bleeding Rate After EGD and Colonoscopy in Patients Who Continue to Take Antithrombotic Agents
Recruiting
- Conditions
- Bleeding After GI Endoscopy
- First Posted Date
- 2015-11-03
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Showa Inan General Hospital
- Target Recruit Count
- 10000
- Registration Number
- NCT02594813
- Locations
- π―π΅
Showa Inan General Hospital, Komagane, Japan
Β© Copyright 2025. All Rights Reserved by MedPath